Purchase Order 75N90019P00564
Award Date 7/10/19
Potential Completion Date 7/23/24
Potential Value $88K
Federal Agency
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Burien, WA 98168, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services (HHS). The contract was awarded to Stemcell Technologies Inc., a Canadian biotechnology company that provides specialized cell culture media, cell separation systems, and other life sciences research products. The contract is for the provision of a RoboSep LTD warranty with a preventive maintenance package for a...
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Stemcell Technologies Inc., a subsidiary of the Canadian biotechnology company Stemcell Technologies. The $7,725.00 firm fixed-price purchase order is for a RoboSep LTD warranty with a preventative maintenance package, providing one year of service support for the automated cell separation instrument. The contract is not set aside...
- This federal contract award is for STEMCELL Technologies Inc. to provide reagents and consumables for the RoboSep-S Cell Separator Systems used at the National Institutes of Health (NIH) Clinical Center. The award, valued at $39,232.00, is a Firm Fixed Price Purchase Order issued on a sole source basis, as STEMCELL Technologies Inc. is the only known vendor capable of supplying the proprietary supplies required for the existing RoboSep-S instruments at the NIH Clinical Center. The contract...
- This federal contract award, valued at $54,102.50, was issued by the National Institute of Environmental Health Sciences (NIEHS) to Stemcell Technologies Inc., a foreign-owned, for-profit biotechnology company based in Canada with a U.S. presence in Kent, Washington. The contract is for the acquisition of a RoboSep-S automated cell separator, which uses EasySep immunomagnetic cell separation technology to enable positive and negative selection of desired cells from various sample sources. This...
- This is a firm fixed-price purchase order awarded by the Office of Logistics and Acquisition Operations, a civilian agency within the Department of Health and Human Services, to Stemcell Technologies Inc., a Canadian biotechnology company, to purchase a RoboSep-S automated cell separation system with a 5-year warranty and maintenance service. The contract, valued at $94,612.00, does not have a small business set-aside designation. Stemcell Technologies Inc. is a subsidiary of the Canadian parent...
- This is a firm fixed-price delivery order for $47,405.00 awarded by the National Institute on Aging (NIA), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Stemcell Technologies Inc., a foreign-owned, for-profit biotechnology company based in Canada. The contract is for a fully automated cell separator system called RoboSep, which automates the labeling and magnetic separation of cells, supporting the NIA's biomedical research activities. This contract is not...
- This is a federal contract award from the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Stemcell Technologies Inc., a foreign-owned, for-profit biotechnology company headquartered in Canada. The $7,131.73 firm fixed-price contract is a Blanket Purchase Agreement (BPA) call for T-cell isolation products needed for research in Dr. Kemper's lab. Stemcell Technologies Inc. is a key supplier of advanced biological materials, laboratory...
- This federal contract award to Stemcell Technologies Inc., a Canadian biotechnology company, is for the purchase of four RoboSep Limited Warranty units (Catalog # 20200, S/N RS-1232) at a total ceiling value of $14,970.00. The contract was awarded on February 16, 2012 by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS). The award does not have a set-aside designation. As a prime contractor, Stemcell...
- This is a firm fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Stemcell Technologies Inc., a foreign-owned, for-profit biotechnology company headquartered in Canada. The $84,089.26 contract is for the provision of specialized biological materials, laboratory supplies, and scientific equipment to support biomedical research across various NIH institutes and centers, including the National Institute of Allergy and Infectious Diseases,...
- This is a firm fixed-price purchase order contract awarded by the Office of the Chief Operating Officer, a civilian agency, to Stemcell Technologies Inc., a for-profit Canadian biotechnology company. The contract, valued at $14,677.50, is for the provision of maintenance services for Stemcell Technologies' proprietary research tools and supplies. Stemcell Technologies Inc. is the prime contractor and there is no indication of any major subcontractors. The contract is not set aside for small...